Suppr
超能文献

More genes, more problems? Benefits and risks of multiplex genetic testing.

作者信息

Norquist Barbara M, Swisher Elizabeth M

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.

出版信息

Gynecol Oncol. 2015 Nov;139(2):209-10. doi: 10.1016/j.ygyno.2015.10.013.

DOI:10.1016/j.ygyno.2015.10.013

PMID:26521152

Abstract

摘要

相似文献

More genes, more problems? Benefits and risks of multiplex genetic testing.

Gynecol Oncol. 2015 Nov;139(2):209-10. doi: 10.1016/j.ygyno.2015.10.013.

Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.

Breast J. 2019 Jul;25(4):575-577. doi: 10.1111/tbj.13292.

Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia.

Intern Med J. 2018 Oct;48(10):1269-1272. doi: 10.1111/imj.14058.

Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.

Patient Educ Couns. 2018 May;101(5):938-944. doi: 10.1016/j.pec.2017.12.011. Epub 2017 Dec 12.

Uptake of Cascade Genetic Testing for Hereditary Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.

Clin Obstet Gynecol. 2024 Dec 1;67(4):702-710. doi: 10.1097/GRF.0000000000000895. Epub 2024 Oct 18.

Population-based genetic testing for Women's cancer prevention.

Best Pract Res Clin Obstet Gynaecol. 2020 May;65:139-153. doi: 10.1016/j.bpobgyn.2020.02.007. Epub 2020 Mar 2.

Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.

J Med Genet. 2016 Jan;53(1):34-42. doi: 10.1136/jmedgenet-2015-103452. Epub 2015 Nov 3.

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.

Breast Cancer Res Treat. 2016 Dec;160(3):393-410. doi: 10.1007/s10549-016-4003-9. Epub 2016 Oct 12.

Novel BRCA1 Large Genomic Rearrangements in Italian Breast/Ovarian Cancer Patients.

Mol Diagn Ther. 2019 Feb;23(1):121-126. doi: 10.1007/s40291-018-0376-2.

The changing landscape of genetic testing for hereditary breast and ovarian cancer.

Curr Probl Cancer. 2014 Nov-Dec;38(6):209-15. doi: 10.1016/j.currproblcancer.2014.10.001. Epub 2014 Oct 30.

引用本文的文献

The impact of the number of tests presented and a provider recommendation on decisions about genetic testing for cancer risk.

Patient Educ Couns. 2021 Feb;104(2):265-275. doi: 10.1016/j.pec.2020.09.020. Epub 2020 Sep 18.

Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan.

J Community Genet. 2020 Jul;11(3):359-366. doi: 10.1007/s12687-020-00456-6. Epub 2020 Feb 24.

Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families.

J Community Genet. 2018 Jan;9(1):81-92. doi: 10.1007/s12687-017-0322-8. Epub 2017 Oct 2.

Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.

Int J Gynecol Cancer. 2018 Jan;28(1):26-33. doi: 10.1097/IGC.0000000000001122.

Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature.

Gynecol Oncol Res Pract. 2017 Feb 22;4:4. doi: 10.1186/s40661-017-0039-8. eCollection 2017.

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.

J Genet Couns. 2017 Aug;26(4):866-877. doi: 10.1007/s10897-017-0066-y. Epub 2017 Jan 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

More genes, more problems? Benefits and risks of multiplex genetic testing.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译